According to China Dasheng Biotechnology latest financial reports the total liabilities of CDBT is $1.69M, an increase of 5535.93% to 2022. At the end of 2022 company had $30.00K total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that China Dasheng Biotechnology is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $1.69M | 5535.93% |
2022 | $30.00K | - |